Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Resilinc Named a Technology Provider by Automotive Industry Action Group for Forced Labor Risk Management
-
Sampo plc: Managers’ Transactions (Wennerklint)
-
VEON’s Cloud & Cybersecurity Platform Garaj Signs with Standard Chartered Bank in Pakistan
-
Thesys Raises $4M Led by Together Fund to Shape the Future of AI-Driven Interfaces
-
Illumio Expands Partner Program in Response to Rising Demand for Zero Trust Segmentation
-
LPL Financial Welcomes S&G Wealth Partners
-
LPL Financial Welcomes S&G Wealth Partners
-
Form 8.3 - Learning Technologies Group plc - Octopus Investments
-
MAX Power Makes Strategic Management Move to Accelerate Natural Hydrogen Opportunities
-
Vault Verify Enhances Industry-Leading Vault EDGe Gateway
-
New Muck Rack Report Reveals Half of PR Pros Only “Somewhat Confident” in Metrics
-
Orbit International Corp. Reports 2024 Third Quarter Results
-
AITX’s RAD Celebrates Surpassing Major Milestone of 1,000 Devices Deployed and Awaiting Deployment
-
Net Asset Value(s)
-
FuelCell Energy Announces 1-For-30 Reverse Stock Split
-
Banzai Q3 2024 Preliminary Financial Results: Profitability in Sight Following $14.5M Annualized Adjusted Net Income Improvement; 31% Annualized ARR Growth Rate
-
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma
-
CSW Industrials Deploys $40 Million of Acquisition Capital in Profitable Plumbing End Market
-
Alto Ingredients Publishes its Annual Sustainability Report
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024
-
Perma-Fix Environmental Services Announces Successful Startup of its First Commercial Perma-FAS System for PFAS Destruction
-
Palvella Therapeutics Announces First Patient Dosed in SELVA Phase 3 Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic Malformat
-
Identity and Access Management and Biometric Solutions Provider BIO-key Hosts Q3 Investor Call Friday, November 15th at 10am ET
-
KBW Earns Multiple No. 1 Spots in Influential Rankings
-
CervoMed to Participate in Upcoming Investor Conferences
-
Bel Fuse Announces Upcoming Investor Conference Schedule for November 2024
-
Palisade Bio Announces First Subject Dosed in Phase 1 Clinical Study of PALI-2108 for the Treatment of Moderate-to-Severe Ulcerative Colitis (UC)
-
Intelligent Bio Solutions Reports Fiscal 2025 First Quarter Financial Results and Operational Highlights
-
ConnectM to Participate in the 13th Annual Roth Technology Conference
-
KYN Capital Group Enhances KOINFOLD With Faster Transaction Speeds
-
PodcastOne (NASDAQ: PODC) Reports Q2 Fiscal 2025 Financial Results; Revenue Increases 16% YoY to $12.2 Million
-
KBW Earns Multiple No. 1 Spots in Influential Rankings
-
Ikena Oncology Reports Third Quarter 2024 Financial Results
-
Paltalk to Host Third Quarter 2024 Earnings Results Conference Call on Tuesday, November 12, 2024 at 4:30 p.m. ET
-
Workhorse Secures Multiple Orders for W56 Electric Step Vans in Parcel Delivery Market as Fleet Demand Increases
-
Volaris Reports October 2024 Traffic Results: Strong Demand Across Our Markets, Load Factor of 87%
-
Horizon Aircraft Simplifies Capital Structure with Mutual Termination of Forward Purchase Agreement with Meteora Capital
-
iCoreConnect Announces Expansion of Endorsement With The Arizona Dental Association (AzDA)
-
Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC
-
HYCU® Unveils Enhanced Data Protection for Box, Enabling Enterprise-Grade Backup and Recovery for More Than 115,000+ Organizations Worldwide
-
Saratoga Investment Corp. Announces Quarterly Dividend of $0.74 Per Share for the Fiscal Third Quarter Ending November 30, 2024
-
3D Systems Empowers Innovation, Transforms Industries with New Products at Formnext 2024
-
HeartCore to Present at Sidoti Micro-Cap Virtual Conference on November 14, 2024 at 11:30 a.m. ET
-
Femasys to Exhibit at the Annual AAGL 2024 Global Conference
-
Nexxen to Participate in the RBC Global Technology, Internet, Media and Telecommunications Conference
-
La Rosa Holdings to Unveil Proprietary Technology Advancements at Growth Summit 2024
-
2024 Guangxi Culture and Tourism Development Conference to Commence Soon
-
AdSure Invites Advertisers to Access Top-Quality Finance and Insurance Leads – 10% Conversion Guarantee for Top Funnel Live Leads
-
Trinity Biotech Regains Compliance with Nasdaq Listing Requirements
-
Enlight Announces a Power Purchase Agreement for the Snowflake A Project in Arizona
